Concepedia
Statistics
Publications
7
Citations
230
H-Index
Active since
2017
Affiliations
Oregon Health & Science University(Current)
Millennium Engineering and Integration (United States)
City Of Hope National Medical Center
Portland VA Medical Center
Takeda (United States)
Scott Best is an author at Oregon Health & Science University specializing in oncology, life sciences, and apoptosis.
Publications per year
2017–2023
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
Taylor Hashiguchi, Nur Bruss, Scott Best et al. · Molecular Cancer Therapeutics · 2019 · 58 citations
Medicine, Cancer Biology, Oncology +15
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells
Scott Best, Taylor Hashiguchi, Adam S. Kittai et al. · Blood Advances · 2019 · 55 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
Scott Best, Vi Lam, Tingting Liu et al. · Leukemia · 2020 · 38 citations · Full text
Life Sciences, Immunology, Oncology +16
SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia
Cody Paiva, Taylor Rowland, Bhargava Sreekantham et al. · Haematologica · 2017 · 35 citations · Full text
T Cell–intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia
Vi Lam, Carly Roleder, Tingting Liu et al. · Molecular Cancer Therapeutics · 2023 · 17 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 7